Starting in the late 1950s, thalidomide was prescribed for morning sickness and as a sedative. The drug was banned in 1962 after causing birth defects. New Jersey-based Celgene Corp. won FDA approval to use the drug against a painful side-effect of leprosy and later to treat multiple myeloma.

Starting in the late 1950s, thalidomide was prescribed for morning sickness and as a sedative. The drug was banned in 1962 after causing birth defects. New Jersey-based Celgene Corp. won FDA approval to use the drug against a painful side-effect of leprosy and later to treat multiple myeloma.